COVID–19 Emergency Medical Supplies Enhancement Act of 2021
COVID-19 Emergency Medical Supplies Enhancement Act of 2021 This bill expands certain authorities under the Defense Production Act of 1950 (DPA) and authorizes the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies. The bill makes loans under the DPA subject to certain notification requirements. A report required under the DPA for FY2022 and FY2023 shall include the percentage of contracts awarded to small businesses.
Government Operations and Politics
Administrative law and regulatory procedures
Cardiovascular and respiratory health
Congressional oversight
Drug therapy
Emergency medical services and trauma care
Government lending and loan guarantees
Health promotion and preventive care
Health technology, devices, supplies
Infectious and parasitic diseases
Manufacturing
Medical tests and diagnostic methods
Military procurement, research, weapons development
Public contracts and procurement
Public-private cooperation
Small business
Strategic materials and reserves
Worker safety and health
← Back to Juan Vargas's profile